XSNX — NovAccess Global Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $2.10m
Annual cashflow statement for NovAccess Global, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.34 | -6.77 | -2.51 | -1.72 | -4.72 |
| Depreciation | |||||
| Non-Cash Items | -2.17 | 6.7 | 1.29 | -0.617 | 3.45 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.179 | -0.022 | 0.542 | 1.43 | 0.655 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.007 | -0.093 | -0.682 | -0.903 | -0.625 |
| Capital Expenditures | -0.002 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | 0 | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | -0.002 | 0 | 0 | — | — |
| Financing Cash Flow Items | — | 0.093 | 0.015 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.024 | 0.085 | 0.863 | 0.787 | 0.582 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.033 | -0.008 | 0.18 | -0.116 | -0.043 |